ロード中...
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...
保存先:
| 出版年: | J Investig Med High Impact Case Rep |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448133/ https://ncbi.nlm.nih.gov/pubmed/32830561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709620951339 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|